RTX Corp. Guides FY26 In Line Estimates

RTX (formerly Raytheon Technologies) established fiscal 2026 adjusted guidance of $6.60–$6.80 per share and adjusted sales of $92.0–$93.0 billion, implying 5–6% organic sales growth; the guidance midpoint is essentially in line with the analyst consensus of $6.71 EPS and $92.39B in sales. CEO Chris Calio cited momentum and capacity investments as drivers, and the stock traded up about 2.46% pre-market to $198.89 following the announcement.

Analysis

Market structure: RTX's explicit FY2026 guide (adj. EPS $6.60–6.80; sales $92–93B; organic +5–6%) reinforces prime-contractor pricing power and helps tier‑1 suppliers (e.g., parts/engine vendors) but leaves commercial-only OEMs and airlines exposed to cyclical demand risk. The guidance implies firm backlog conversion and stable margin trends; expect modest re-rating in prime defense equities while supplier credit spreads may tighten in 3–12 months as order visibility improves. Cross-asset: small positive for IG aerospace credit, modest IV compression in RTX options near-term, limited FX/commodity impact except localized metal/logistics inflation pressure on supplier margins.

Risk assessment: Tail risks include DoD budget cuts or program cancellations, major program execution failures, or a slowdown in commercial aviation recovery that hits Pratt/Collins-related sales; low-probability shocks (cyber/production mishap) could erase a year of upside. Immediate (days) — post-guide pop; short-term (weeks/months) — analysts repricing and volatility fade; long-term (quarters/years) — dependent on DoD FY2026–2027 appropriations and FCF conversion of backlog. Hidden dependencies: FCF hinges on capex for capacity expansion and supplier lead times; watch conversion rate and working capital trajectory.

Trade implications: Direct tactical long bias in RTX sized to conviction with downside hedges; prefer cash-secured put entry or covered-call income rather than naked directional leverage given forward PE ~30. Relative value: long RTX vs short commercial aerospace exposure (BA or JETS) to isolate defense-growth. Key catalysts to act on: DoD contract awards, quarterly FCF/backlog conversion, and any organic-growth revisions >±100bp.

Contrarian angles: Consensus underweights execution and FCF risk — market pricing (>~29x forward EPS) demands near-perfect delivery; the modest 2–3% stock move suggests underreaction rather than exuberance, leaving room for both upside on beat and sharp downside on slip. Historical parallels: primes have seen multiple compression when capacity expansion precedes FCF realization. A constrained FCF-to-net-income ratio (<10% for two quarters) would be a clear early warning to reduce exposure.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in RTX (NYSE:RTX) size-weighted between $190–$205; set a stop-loss at -10% and a 12-month take-profit target of $230 (+15%) with partial trims at +8% and +15%.
• Sell 60-day cash-secured puts on RTX at the $180 strike size-equivalent to 1–2% notional to acquire stock at ~9–10% discount to current price; roll/assign if put premium <3% of strike or implied vol spikes >25%.
• If long RTX, sell 90-day covered calls at the $210 strike (~+5% upside) to generate yield; roll only if IV increases >20% or if quarterly signals (EPS < $6.60 or organic growth <4.0%) are missed.
• Implement a pair trade: go long RTX 2% and short BA (Boeing) 1.5% or short JETS ETF 1.5% to hedge commercial aerospace cyclicality; rebalance if RTX/BA spread diverges >15% from entry within 3 months.
• Set explicit monitoring/triggers: cut RTX exposure by 50% if FCF conversion falls below 10% of net income for two consecutive quarters or if FY2026 organic growth guidance is revised below 4.0% — review position within 30–90 days after DoD FY2026 appropriations announcements or major contract awards.